Question

Hi, this is my question,

" Read U.S. Department of Health and Human Services: Developing and implementing a QI plan: Introduction http://www.hrsa.gov/quality/toolbox/methodology/developingandimplementingaqiplan/index.html (alternatively use: https://www.hrsa.gov/sites/default/files/quality/toolbox/508pdfs/developingqiplan.pdf) or search for developing and implementing a qi plan).

identify a healthcare program or issue that needs to be improved. Write a proposal advancing your choice and the rationale behind it (4 paragraphs) This will become the purpose statement for your Quality Improvement Plan and will be entered in a quality improvement plan template during Week 5. "

if the URL not work, please write the paragraphs about any healthcare program or issue that needs to be improved, I need it as typed , not picture please, Thank you

Answer 1

Note: This response is in UK English, please paste the response to MS Word and you should be able to spot discrepancies easily.

(Answer) Title: Quality Improvement Plan on Regulating the Difference in Ratio of Selling Price to Production Cost of Pharmaceuticals

Purpose Statement: Pharmaceutical companies spend the most amount of money on research and development (R&D). This means that even if the initial price of a drug is high in the market, the cost over time should be able to gradually decrease. Since the cost of R&D will have been recovered, the price of the drug should not bear an extremely significant difference compared to the production cost.

However, the situation in the US is not entirely so. The price of drugs and generic brands have a constant, precipitous gap compared to the production cost. It is the FDA that regulates a quality check on the drug companies in the US and international companies who export pharmaceuticals to the US. However, price regulations are equally a pressing matter that needs to be in check.

Martin Shkreli is a name common to this controversy. In charge of ‘Turing’ pharmaceuticals, Shkreli increased the price of an HIV drug called ‘Darapim’ that contains ‘Pyrimethamine’. He increased the price to about $750 a pill. When a group of Australian STEM students attempted to replicate the drug, they successfully made it at $2 a pill. Such an incident brings to light a kind of malpractice that deserves to be thoroughly looked into.